Details for Patent: 5,635,517
✉ Email this page to a colleague
Title: | Method of reducing TNF.alpha. levels with amino substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxo-and 1,3-dioxoisoindolines |
Abstract: | 1-Oxo- and 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl) isoindolines substituted with amino in the benzo ring reduce the levels of TNF.alpha. in a mammal. A typical embodiment is 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-5-aminoisoindoline. |
Inventor(s): | Muller; George W. (Bridgewater, NJ), Stirling; David I. (Branchburg, NJ), Chen; Roger S. -C. (Edison, NJ) |
Assignee: | Celgene Corporation (Warren, NJ) |
Filing Date: | Jul 24, 1996 |
Application Number: | 08/690,258 |
Claims: | 1. The method of reducing undesirable levels of TNF.alpha. in a mammal which comprises administering thereto an effective amount of a compound of the formula: ##STR3## in which in said compound one of X and Y is C.dbd.O and the other of X and Y is C.dbd.O or CH.sub.2. 2. The method according to claim 1 in which X is C.dbd.O and Y is CH.sub.2. 3. The method according to claim 2 in which said compound is 1-oxo-2-(2,6-dioxopiperidin-3-yl)-5-aminoisoindoline. 4. The method according to claim 2 in which said compound is 1-oxo-2-(2,6-dioxopiperidin-3 -yl)-4-aminoisoindoline. 5. The method according to claim 2 in which said compound is 1-oxo-2-(2,6-dioxopiperidin-3 -yl)-6-aminoisoindoline. 6. The method according to claim 2 in which said compound is 1-oxo-2-(2,6-dioxopiperidin-3 -yl)-7-aminoisoindoline. 7. The method according to claim 1 in which each of X and Y is C.dbd.O. 8. The method according to claim 7 in which said compound is 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline. 9. The method according to claim 7 in which said compound is 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-5-aminoisoindoline. 10. A compound selected from the group consisting of 1-oxo-2-(2,6-dioxopiperidin-3-yl)-5-aminoisoindoline, 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline, 1-oxo-2-(2,6-dioxopiperidin-3-yl)-6-aminoisoindoline, and 1-oxo-2-(2,6-dioxopiperidin-3-yl)-7-aminoisoindoline. |